Access to anti-retroviral drugs, male in Bulgaria

Bulgaria: Access to anti-retroviral drugs, male was 63.0% in 2024. ◆ Volatile

Latest (2024)
63.0%
Change on year
up 1.6%
World rank
92nd
of 141 countries
All-time high
63.0%
in 2024
All-time low
4.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Bulgaria, 2000–2024

02040602000201220242000: 4 %2001: 5 %2002: 5 %2003: 8 %2004: 8 %2005: 9 %2006: 9 %2007: 11 %2008: 12 %2009: 15 %2010: 17 %2011: 19 %2012: 22 %2013: 25 %2014: 28 %2015: 32 %2016: 37 %2017: 44 %2018: 52 %2019: 56 %2020: 57 %2021: 59 %2022: 61 %2023: 62 %2024: 63 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Bulgaria stood at 63.0%. That is the highest value across all 25 years on record.

That represents a change of up 1.6% on the previous year and up 125.0% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Bulgaria peaked at 63.0% in 2024 and was at its lowest, 4.0%, in 2000.

Bulgaria ranks 92nd of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Bulgaria, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Bulgaria, 2000 to 2024.
Year % Change
2000 4.0%
2001 5.0% +25.0%
2002 5.0% +0.0%
2003 8.0% +60.0%
2004 8.0% +0.0%
2005 9.0% +12.5%
2006 9.0% +0.0%
2007 11.0% +22.2%
2008 12.0% +9.1%
2009 15.0% +25.0%
2010 17.0% +13.3%
2011 19.0% +11.8%
2012 22.0% +15.8%
2013 25.0% +13.6%
2014 28.0% +12.0%
2015 32.0% +14.3%
2016 37.0% +15.6%
2017 44.0% +18.9%
2018 52.0% +18.2%
2019 56.0% +7.7%
2020 57.0% +1.8%
2021 59.0% +3.5%
2022 61.0% +3.4%
2023 62.0% +1.6%
2024 63.0% +1.6%

Averages by decade

DecadeAverage LowestHighest Years
2000s 8.6% 4.0% 15.0% 10
2010s 33.2% 17.0% 56.0% 10
2020s 60.4% 57.0% 63.0% 5

Countries ranked near Bulgaria

  1. 92 Somalia 63.0% compare
  2. 94 Bhutan 62.0% compare
  3. 94 Guinea-Bissau 62.0% compare
  4. 94 Timor-Leste 62.0% compare

See the full ranking of 160 places →

More gender data for Bulgaria

All data for Bulgaria →

Frequently asked questions

What is access to anti-retroviral drugs, male in Bulgaria?
Access to anti-retroviral drugs, male in Bulgaria was 63.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Bulgaria?
The highest recorded value was 63.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Bulgaria?
The lowest recorded value was 4.0% in 2000.
How does Bulgaria rank for access to anti-retroviral drugs, male?
Bulgaria ranks 92nd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Bulgaria?
Over the last ten years it is up 125.0%. The long-run trend across the full record is volatile.
Where does this Bulgaria data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Bulgaria. Statizoid, drawing on UNAIDS estimates. Retrieved 09 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/bulgaria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/bulgaria/">Access to anti-retroviral drugs, male in Bulgaria</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.